Quality Assurance of Dose Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal Cancer.
Fiche publication
Date publication
juillet 2019
Journal
International journal of radiation oncology, biology, physics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier, Dr BOUSTANI Jihane
Tous les auteurs :
Boustani J, Del Campo ER, Blanc J, Peiffert D, Benezery K, Pereira R, Rio E, Le Prisé E, Créhange G, Huguet F
Lien Pubmed
Résumé
The ongoing phase II/III XXX trial compares chemoradiotherapy with and without dose escalation in patients with locally advanced or unresectable oesophageal cancer. The results of a benchmark case procedure are reported here to evaluate the protocol compliance of participating centers as part of a quality assurance for radiation therapy (QART).
Mots clés
IMRT, adenocarcinoma, benchmark case, chemoradiotherapy, dose escalation, external beam radiotherapy, oesophageal carcinoma, oxaliplatine, quality assurance, squamous cell
Référence
Int. J. Radiat. Oncol. Biol. Phys.. 2019 Jul 9;: